A detailed history of Jupiter Asset Management LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Jupiter Asset Management LTD holds 9,147 shares of ALNY stock, worth $2.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,147
Holding current value
$2.3 Million
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$233.81 - $287.01 $2.14 Million - $2.63 Million
9,147 New
9,147 $2.52 Million
Q1 2021

May 12, 2021

SELL
$126.83 - $175.69 $1.79 Million - $2.48 Million
-14,139 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$122.97 - $147.0 $1.74 Million - $2.08 Million
14,139 New
14,139 $1.84 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.